Fluda, Germany

Juliane Medler

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Julius-Maximilians-Universitat Wurzburg. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juliane Medler. Retrieved from https://idiyas.com/inventor/juliane-medler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Juliane Medler: Inventor in Biomedical Research

Introduction

Juliane Medler is an inventor associated with Julius-Maximilians-Universität Würzburg in Germany. Her work includes a patent concerning antibody fusion proteins designed to activate members of the tumor necrosis factor receptor superfamily.

Latest Patents

Medler is listed as an inventor on 1 patent: “Tumor Necrosis Factor (TNF) Receptor Superfamily (TNFRSF) Receptor-Activating Antibody Fusion Proteins with FcγR-Independent Agonistic Activity (TRAAFFIAA).” The invention addresses receptor-activating antibody fusion proteins with agonistic activity that does not depend on Fcγ receptors.

Career Highlights

The available information connects Medler’s patent work with Julius-Maximilians-Universität Würzburg. Her listed invention focuses on antibody-based approaches involving TNF receptor superfamily signaling.

Collaborations

Medler’s listed coworkers include Johannes Nelke and Andreas Beilhack.

Conclusion

Juliane Medler’s recorded patent activity highlights her contribution to biomedical innovation through research on FcγR-independent TNFRSF receptor-activating antibody fusion proteins.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…